166 related articles for article (PubMed ID: 7581490)
1. Molecular biomarkers for aflatoxins and their application to human liver cancer.
Scholl P; Musser SM; Kensler TW; Groopman JD
Pharmacogenetics; 1995; 5 Spec No():S171-6. PubMed ID: 7581490
[TBL] [Abstract][Full Text] [Related]
2. Molecular biomarkers for aflatoxins: from adducts to gene mutations to human liver cancer.
Groopman JD; Wang JS; Scholl P
Can J Physiol Pharmacol; 1996 Feb; 74(2):203-9. PubMed ID: 8723033
[TBL] [Abstract][Full Text] [Related]
3. Role of metabolism and viruses in aflatoxin-induced liver cancer.
Groopman JD; Kensler TW
Toxicol Appl Pharmacol; 2005 Aug; 206(2):131-7. PubMed ID: 15967201
[TBL] [Abstract][Full Text] [Related]
4. Aflatoxin and hepatitis B virus biomarkers: a paradigm for complex environmental exposures and cancer risk.
Groopman JD; Johnson D; Kensler TW
Cancer Biomark; 2005; 1(1):5-14. PubMed ID: 17192028
[TBL] [Abstract][Full Text] [Related]
5. Use of aflatoxin adducts as intermediate endpoints to assess the efficacy of chemopreventive interventions in animals and man.
Kensler TW; Groopman JD; Roebuck BD
Mutat Res; 1998 Jun; 402(1-2):165-72. PubMed ID: 9675269
[TBL] [Abstract][Full Text] [Related]
6. The toxicology of aflatoxins as a basis for public health decisions.
Wild CP; Turner PC
Mutagenesis; 2002 Nov; 17(6):471-81. PubMed ID: 12435844
[TBL] [Abstract][Full Text] [Related]
7. Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review.
Wogan GN; Kensler TW; Groopman JD
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2012; 29(2):249-57. PubMed ID: 21623489
[TBL] [Abstract][Full Text] [Related]
8. Molecular biomarkers for aflatoxins and their application to human cancer prevention.
Groopman JD; Wogan GN; Roebuck BD; Kensler TW
Cancer Res; 1994 Apr; 54(7 Suppl):1907s-1911s. PubMed ID: 8137310
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of the resistance to cytotoxicity which precedes aflatoxin B1 hepatocarcinogenesis.
Neal GE; Metcalfe SA; Legg RF; Judah DH; Green JA
Carcinogenesis; 1981; 2(5):457-61. PubMed ID: 6791858
[No Abstract] [Full Text] [Related]
10. Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans.
Groopman JD; Wild CP; Hasler J; Junshi C; Wogan GN; Kensler TW
Environ Health Perspect; 1993 Mar; 99():107-13. PubMed ID: 8319607
[TBL] [Abstract][Full Text] [Related]
11. Aflatoxin B1-2,3-oxide as a probable intermediate in the covalent binding of aflatoxins B1 and B2 to rat liver DNA and ribosomal RNA in vivo.
Swenson DH; Lin JK; Miller EC; Miller JA
Cancer Res; 1977 Jan; 37(1):172-81. PubMed ID: 187331
[TBL] [Abstract][Full Text] [Related]
12. Impacts of chemicals on liver cancer risk.
Wogan GN
Semin Cancer Biol; 2000 Jun; 10(3):201-10. PubMed ID: 10936069
[TBL] [Abstract][Full Text] [Related]
13. Molecular dosimetry in fish: quantitative target organ DNA adduction and hepatocarcinogenicity for four aflatoxins by two exposure routes in rainbow trout.
Bailey GS; Dashwood R; Loveland PM; Pereira C; Hendricks JD
Mutat Res; 1998 Mar; 399(2):233-44. PubMed ID: 9672662
[TBL] [Abstract][Full Text] [Related]
14. Quantitative carcinogenesis and dosimetry in rainbow trout for aflatoxin B1 and aflatoxicol, two aflatoxins that form the same DNA adduct.
Bailey GS; Loveland PM; Pereira C; Pierce D; Hendricks JD; Groopman JD
Mutat Res; 1994 Aug; 313(1):25-38. PubMed ID: 7519308
[TBL] [Abstract][Full Text] [Related]
15. Reduced carcinogenic effects of aflatoxin in rats given phenobarbitone.
McLean AE; Marshall A
Br J Exp Pathol; 1971 Jun; 52(3):323-9. PubMed ID: 5090689
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma: from gene to public health.
Montesano R; Hainaut P; Wild CP
J Natl Cancer Inst; 1997 Dec; 89(24):1844-51. PubMed ID: 9414172
[TBL] [Abstract][Full Text] [Related]
17. Environmental and chemical carcinogenesis.
Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
[TBL] [Abstract][Full Text] [Related]
18. Carcinogen-DNA and protein adducts: biomarkers for cohort selection and modifiable endpoints in chemoprevention trials.
Kensler TW; Groopman JD
J Cell Biochem Suppl; 1996; 25():85-91. PubMed ID: 9027603
[TBL] [Abstract][Full Text] [Related]
19. Aflatoxin biomarkers in hair may facilitate long-term exposure studies.
Mupunga I; Izaaks CD; Shai LJ; Katerere DR
J Appl Toxicol; 2017 Apr; 37(4):395-399. PubMed ID: 27933645
[TBL] [Abstract][Full Text] [Related]
20. Protective activity of different hepatic cytosolic glutathione S-transferases against DNA-binding metabolites of aflatoxin B1.
Quinn BA; Crane TL; Kocal TE; Best SJ; Cameron RG; Rushmore TH; Farber E; Hayes MA
Toxicol Appl Pharmacol; 1990 Sep; 105(3):351-63. PubMed ID: 2173169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
